Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ibandronic acid 150mg tablets.
Tier 2 – medium impact
Date of issue: 17th November 2025
- Ibandronic acid 150mg tablets, the only licensed once monthly bisphosphonate, are in limited supply until March 2026.
- Alendronic acid 70mg tablets and risedronate sodium 35mg tablets (once weekly bisphosphonate presentations) remain available and can support increased demand.
A copy of this medicine supply notification, including supporting information, has been sent to all pharmacy NHS email addresses.
DHSC and NHS England have launched an online Medicines Supply Tool, which provides up-to-date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
The post Medicine Supply Notification: Ibandronic acid 150mg tablets appeared first on Community Pharmacy England.